<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Genetic analysis of the merozoite surface protein-1 block 2 allelic types in Plasmodium falciparum clinical isolates from Lao PDR</title>
<meta name="Subject" content="Malaria Journal 2011, 10:371. doi:10.1186/1475-2875-10-371"/>
<meta name="Keywords" content=" "/>
<meta name="Author" content="Naly Khaminsou"/>
<meta name="Creator" content="Arbortext Advanced Print Publisher 10.0.1082/W Unicode"/>
<meta name="Producer" content="Acrobat Distiller 9.4.2 (Windows)"/>
<meta name="CreationDate" content=""/>
</head>
<body>
<pre>
Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

RESEARCH

Open Access

Genetic analysis of the merozoite surface
protein-1 block 2 allelic types in Plasmodium
falciparum clinical isolates from Lao PDR
Naly Khaminsou1†, Onanong Kritpetcharat2†, Jureerut Daduang3†, Lertchai Charerntanyarak4 and
Panutas Kritpetcharat5*

Abstract
Background: MSP-1 is one of the potential malarial vaccine candidate antigens. However, extensive genetic
polymorphism of this antigen in the field isolates of Plasmodium falciparum represents a major hindrance for the
development of an effective vaccine. Therefore, this study aimed to establish the prevalence and genetic
polymorphisms of K1, MAD20 and RO33 allelic types of msp-1 block 2 among P. falciparum clinical isolates from
Lao PDR.
Methods: Plasmodium falciparum isolates were collected from 230 P. falciparum-infected blood samples from three
regions of Lao PDR. K1, MAD20 and RO33 were detected by nested PCR; SSCP was used for polymorphism
screening. The nested PCR products of each K1, MAD20 and RO33 allelic types that had different banding patterns
by SSCP, were sequenced.
Results: The overall prevalence of K1, MAD20 and RO33 allelic types in P. falciparum isolates from Lao PDR were
66.95%, 46.52% and 31.30%, respectively, of samples under study. Single infections with K1, MAD20 and RO33
allelic types were 27.83%, 11.74% and 5.22%, respectively; the remainders were multiple clonal infections. Neither
parasite density nor age was related to MOI. Sequence analysis revealed that there were 11 different types of K1,
eight different types of MAD20, and 7 different types of RO33. Most of them were regional specific, except type 1
of each allelic type was common found in 3 regions under study.
Conclusions: Genetic polymorphism with diverse allele types was identified in msp-1 block 2 among P. falciparum
clinical isolates in Lao PDR. A rather high level of multiple clonal infections was also observed but the multiplicity
of infection was rather low as not exceed 2.0. This basic data are useful for treatment and malaria control program
in Lao PDR.

Background
Malaria remains one of the most important health-threatening parasitic diseases in tropical and subtropical areas,
such as Lao PDR and other countries in Southeast Asia. In
Lao PDR, many highly endemic areas exist, especially in
the rural areas of Xekong, Attapeu, Savannakhet, Saravane,
and Champasack provinces [1-3]. Plasmodium falciparum
is responsible for most of the mortality, while Plasmodium
vivax causes considerable morbidity [1,3,4]. Despite the
* Correspondence: panutas@kku.ac.th
† Contributed equally
5
Department of Clinical Microscopy, Faculty of Associated Medical Sciences,
Khon Kaen University, 123 Mittraphap Highway, Khon Kaen 40002, Thailand
Full list of author information is available at the end of the article

enormous efforts that have been directed toward malaria
control and prevention, multiple factors-including insecticide resistance in anopheline vectors, the lack of effective
vaccines, and the emergence and rapid spread of drugresistant strains-are the major problems for controlling
and prevention of malaria. Therefore, the development of
an effective malaria vaccine is urgently needed. However,
extensive the genetic diversity in natural malaria parasite
populations is a major obstacle for the development of an
effective vaccine against these parasites, because antigenic
diversity limits the efficiency of acquired protective immunity to malaria [5-7]. Many malarial proteins have been
proposed for use as vaccine candidate antigens, but

© 2011 Khaminsou et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

merozoite surface protein-1 (MSP-1) is the most used
[8,9]. However, extensive genetic polymorphisms of the
MSP-1 gene have been identified in P. falciparum isolates
worldwide; this has caused extensive antigenic polymorphism [10,11]. It is important to investigate the diversity of
msp-1 gene, in different geographic areas for the further
development of effective malaria prevention and control.
MSP-1, with an approximate molecular size of 190 kDa,
is a major surface protein of P. falciparum, and plays a
role in erythrocyte invasion by the merozoite [12]. The
protein is a principal target of human immune responses
[13-15] and is a vaccine candidate antigen for blood stages
[12-16]. The msp-1 gene has 7 variable blocks that are
separated either by semi-conserved or conserved regions.
Block 2, a region near the N-terminal of this gene, is the
most polymorphic part of the protein and appears to be
under the strongest diversifying selection within natural
populations [12]. At present, four different allelic types of
block 2 have been identified, including K1, MAD20, RO33
and MR [17,18].
The overall prevalence of malarial infection in Lao PDR
recoded in 2008 by the Central of Malaria, Parasitology
and Entomology of Lao PDR was 15% [Unpublished data].
At present, there is no data about the genetic diversity of
P. falciparum in Lao PDR. For this reason, it is important
to investigate the diversity of msp-1 gene, in different geographic areas for the further development of effective
malaria prevention and control.
This study aimed to establish the prevalence and genetic
polymorphisms of K1, MAD20 and RO33 allelic types of
the msp-1 gene among P. falciparum field isolates from
Lao PDR.

Methods
Study areas

Oudomxay province is situated in northern region; there is
a 15-kilometer border with the autonomous area of
Xishuangbanna of the People’s Republic of China. Some
23 ethnic minorities mainly Hmong, Akha and Khamu
populate Oudomxay. The prevalence of malarial infection
in 2008 recorded by the Central of Malaria, Parasitology
and Entomology of Lao PDR of this area was 0.9% [unpublished data]. Savannakhet province is situated on the banks
of the Mekong River opposite Mukdahan province in
Thailand. The province located in central region and
bridges the country between Thailand and Vietnam. There
are 11 ethnic minorities include Lowland Lao, Phoutai,
Thai Dam, Katang, Mongkong, Vali, Lava, Soui, Kapo,
Kaleung and Ta-Oi. The prevalence of malarial infection
in Savannakhet was 9.4% in 2008. Xekong province is situated in southern region; has common border Vietnam to
the east. Less than 5% of the population is ethnic Lao. The
vast majority comes from one of at least 14 distinct ethnic
minority groups. The main ethnic groups are Alak, Katu,

Page 2 of 14

Tarieng and Nge/Krieng. The prevalence of malarial infection in Xekong was 5% in 2008. The map of this study
area was shown in Figure 1.
Blood samples and genomic DNA extraction

Plasmodium falciparum isolates were collected from
microscopically diagnosed P. falciparum-positive subjects
(from thin and/or thick Giemsa-stained blood films) in
three regions of Lao PDR: the northern region, in Oudomxay province; the central region, in Savannakhet province;
and the southern region, in Xekong province (Figure 1)
and demographics of this study was shown in Table 1.
Blood was spotted on Whatman No. 3 filter paper strips
by pricking a finger or using the leftover EDTA blood
samples from routine work (after obtaining the consent of
parents or guardians in the case of children). The 230
samples-15 from Oudomxay, 140 from Savannakhet and
75 from Xekong-were randomly collected during July
2008 to May 2009. The National Ethics Committee, Lao
PDR, and the Institutional Ethics Board at Khon Kaen
University, Thailand approved this study. All dried blood
samples were extracted for genomic DNA using the Chelex-100 method, as described by Bereczky et al. [19]. The
parasitaemia of blood was the number of parasites per μl
of blood in a thick smear assuming a leukocyte count of
8,000 cells/μl [20].
Nested PCR for Plasmodium falciparum

All extracted DNA samples were confirmed for Plasmodium infection by using nested PCR, as described by
Snounou et al. [21]. Genus-specific primers and speciesspecific primers of P. falciparum, P. vivax, Plasmodium
malariae and Plasmodium ovale were used in this study.
Blood samples infected by Plasmodium species other than
P. falciparum, or by mixed species, were excluded.
Nested PCR for msp-1 block 2, SSCP for polymorphism
screening and DNA sequencing

The msp-1 block 2 allelic types (K1, MAD20 and RO33) of
P. falciparum isolates were detected using the method
described in Aubouy et al. [22]. The primers for msp-1
used in this study are shown in Table 2.
The first round of PCR was done with the external 5’
and 3’ primers, which amplified msp-1 block 2 plus
some of the flanking regions. The first round of amplification was carried out in 25 μl of reaction mix containing: 1× PCR, 4.0 mM MgCl 2 , 0.1 mg/ml gelatin,
0.05% Triton X-100, 200 μM dNTP mix, 0.8 U Taq
polymerase, 75 nM of each conserved primer, distilled
water up to 20 μl, and 5 μl of DNA template. Amplification was performed using the following conditions:
94°C for 5 min, 35 cycles at 94°C for 30 s, 58°C for
1 min, and 72°C for 1 min, followed by extension at
72°C for 10 min.

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 3 of 14

Figure 1 Lao PDR map. Arrows indicate blood sample collection sites: Oudomxay province represented the northern region, Savannakhet the
central region, and Xekong the southern region.

Table 1 Demographics of the studied population
Characteristics

Oudomxay No. (%)

Savannakhet No. (%)

Xekong No. (%)

Total No. (%)

Gender
Male

10 (4.35)

61 (26.52)

45 (19.57)

116 (50.43)

Female

5 (2.17)

79 (34.35)

30 (13.04)

114 (49.57)

Age group
<5

6 (2.61)

51 (22.17)

19 (8.26)

76 (33.04)

5-19

8 (3.48)

59 (25.65)

27 (11.74)

94 (40.87)

20-39

1 (0.43)

21 (9.13)

17 (7.39)

39 (16.96)

40-59

0

9 (3.91)

10 (4.35)

19 (8.26)

≥ 60

0

0

2 (0.87)

2 (0.87)

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 4 of 14

Table 2 Sequences of oligonucleotide primers used to amplify msp-1 block 2 (K1, MAD20 and RO33) allelic types of
Plasmodium falciparum [22]
Primers

Sequences

Note

msp1-C1

5’-AAGCTTTAGAAGATGCAGTATTGAC-3’

Conserved

msp1-C2

5’-ATTCATTAATTTCTTCATATCCATC-3’

Conserved

K1a
K1b

5’-GAAATTACTACAAAAGGTGCAAGTG-3’
5’-AGATGAAGTATTTGAACGAGGTAAAGTG-3’

K1 family-specific
K1 family-specific

MAD20a

5’-AAATGAAGGAACAAGTGGAACAGCTGTTAC-3’

MAD20 family-specific

MAD20b

5’-ATCTGAAGGATTTGTACGTCTTGAATTACC-3’

MAD20 family-specific

RO33a

5’-TAAAGGATGGAGCAAATACTCAAGTTGTTG-3’

RO33 family-specific

RO33b

5’-CATCTGAAGGATTTGCAGCACCTGGAGATC-3’

RO33 family-specific

The second round of PCR was performed in three separate tubes each containing a single pair of K1, MAD20
and RO33 allele-specific primers. The 25 μl reaction mix
contained 1× PCR, 4.0 mM MgCl 2 , 0.1 mg/ml gelatin,
0.05% Triton X-100, 200 μM dNTP mix, 0.8 U Taq polymerase, 75 nM of each allele-specific primer pair (K1a/
K1b, MAD20a/MAD20b or RO33a/RO33b), distilled
water up to 20 μl, and 5 μl of the first-round PCR product.
Amplification cycles for second round PCR were initial
denaturation for 5 min at 94°C, followed by 35 cycles of
30 s denaturation at 94°C, 1 min annealing at 58°C, and
extension at 72°C for 1 min. Final extension was carried
out at 72°C for 10 min. PCR products were visualized by
UV transillumination at 302 nm on gel documentation
system after electrophoresis on 2% agarose gel (Promega/
Boe-hringer) using 0.5 × TBE buffer at 100 volts.
Each DNA product was screened for polymorphic
banding using SSCP, as described in Huby-Chilton et al.
[23], in duplicate: one stained with silver nitrate and the
other with ethidium bromide. The K1, MAD20 and
RO33 products from nested PCR that showed normal
and polymorphic bands were sent for DNA sequencing
by using each forward and reverse primer pair.
Statistical and DNA sequence analysis

A two-proportions test was used to compare the prevalence of msp-1 block 2 allelic types between age groups,
between genders and between parasitaemic groups. To
understand the identity of msp-1 block 2 allelic types of
Lao PDR with respect to isolates of other regions worldwide, sequence data available in the public domain were
downloaded for the following msp-1 allelic types: 3D7 (K1XM 001352134); Thailand (K1-AB276018, K1-AB276008,
MAD20-AB276013, MAD20-AB276006, RO33-AB276015,
RO33-M77737); Vietnam (K1-AF509651, MAD20-AF50
9699, MAD20-AF509696, MAD20-AF509694); Cambodia
(K1-HM153247, MAD20-HM153249); Indonesia (K1AF191061, RO33-AF191064); India (K1-DQ485421, K1DQ485424, RO33-JF300128); Myanmar (K1-GQ861445,
K1-EU445566, MAD20-EU445560, MAD20-EU445555);
Ghana (RO33-AB276005); Malawi (K1-HM153200,

MAD20-HM153237, RO33-HM153239, RO33-HM15
3223); Gambia (MAD20-AB276004); Peru (K1-FJ612037,
K1-FJ612017, RO33-FJ612064); Tanzania (MAD20AF061147, RO33-AF061150); Brazil (MAD20-AF509667,
RO33-AB276002); Iran (RO33-AY138508); Sudan (RO33AB300615); and western Africa (RO33-M55001). DNA
sequence data for each allelic family was aligned together
with other allelic sequences worldwide by using the ClustalW program through BioEdit 5.0.7 software; phylogenetic
trees were created using MEGA 5 [24].

Results
The distribution of msp-1 block 2 allelic types in P. falciparum field isolates from Lao PDR was determined, based
on microscopic diagnosis, from a total of 230 blood samples randomly collected from P. falciparum-infected
patients who attended regional malarial clinics in three
geographic areas of Lao PDR from July 2008 to May 2009:
in Oudomxay province (representing the northern region),
Savannakhet province (central), and Xekong province
(southern). The patients consisted of 116 (50.43%) males
and 114 (49.57%) females: 76 (33.04%) children younger
than 5 years of age; 94 (40.87%) patients whose ages ranged 5-19 years; 39 (16.96%) patients whose ages ranged
20-39 years; 19 (8.26%) patients whose ages ranged 40-59
years; and 2 (0.87%) patients whose ages ≥ 60 years. These
blood samples were confirmed for P. falciparum infection.
All blood samples were typed for msp-1 block 2 K1,
MAD20 and RO33 allelic types by nested PCR. The results
showed that 208 (90.43%) blood samples were positive for
msp-1 block 2 allelic types, while 22 (9.57%) were negative.
Of the total blood samples, 64 (27.83%) were positive for
only the K1 allelic type, 27 (11.74%) for MAD20 only, and
12 (5.22%) for RO33 only (Table 3). The proportion of
multiclonal isolates (multiple clonal infections) and MOI in
different study areas is also given in Table 3. The total of
multiple clonal infections in the three regions of Lao PDR
was 45.65% (105/230 samples), and the proportion of
multiclonal isolates ranged from 26.67% (20/75) in Xekong
(southern region) to 55.71% (78/140) in Savannakhet
(central region). Of the 105 samples showing mixed-allelic

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 5 of 14

Table 3 Prevalence of msp-1 block 2 allelic types in Lao PDR
msp-1 block 2 allelic type

Oudomxay No. (%)

Savannakhet No. (%)

Xekong No. (%)

K1

1(6.66)

39(27.86)

24(32.00)

Total No. (%)
64(27.83)

MAD20

4(26.66)

9(6.43)

14(18.67)

27(11.74)

RO33

1(6.66)

8(5.71)

3(4.00)

12(5.22)

K1 + MAD20

2(13.34)

35(25.00)

8(10.66)

45(19.57)

K1 + RO33

2(13.34)

18(12.86)

5(6.66)

25(10.87)

MAD20 + RO33

2(13.34)

8(5.71)

5(6.66)

15(6.52)

K1 + MAD20 + RO33

1(6.66)

17(12.14)

2(2.66)

20(8.70)

Negative

2(13.34)

6(4.29)

14(18.67)

22(9.57)

15(100.00)

140(100.00)

75(100.00)

230(100.00)

Total K1

6 (40.00)

109(77.86)

39(52.00)

154(66.96)

Total MAD20

9(60.00)

69(49.29)

29(38.67)

107(46.52)

Total RO33

6(40.00)

51(36.43)

15(20.00)

72(31.30)

Multiclonal isolates

7 (46.67)

78 (55.71)

20(26.67)

105(45.65)

1.2

1.7

1.4

Total

MOI

1.6

MOI-Multiplicity of Infection (Number of clones identified as msp1 allelic types, excluding PCR negatives)

types of infection: 45 (19.57% of overall samples) were K1 +
MAD20; 25 (10.87%) K1 + RO33; 15 (6.52%) MAD20 +
RO33, and 20 (8.70%) K1 + MAD20 + RO33 (Table 3).
The prevalence of total K1, MAD20 and RO33 allelic types
was 66.96% (154/230), 46.52% (107/230) and 31.30% (72/
230), respectively, of the study samples. Complexity of
infection (multiplicity of infection, MOI) was estimated by
dividing the total number of fragments detected in the
individual system by the number of samples positive in this
study. MOI was highest (1.7) in Savannakhet province and
lowest in Oudomxay province (1.2). The estimated MOI of
all studied area was 1.6. Clonal fluctuation in each K1,
MAD20 and RO33 allelic type was not observed in P. falciparum clinical isolates under study, so that all the banding
patterns on nested PCR of each allelic type was monomorphic bands as about 200 pb for K1, 180 bp for MAD20
and 150 for RO33.
Age group distribution of P. falciparum-infected patients
under study, and the distribution of msp-1 block 2 allelic

types of P. falciparum field isolates among age groups, is
shown in Table 4. When observing the distribution of
these allelic types in term of two age groupings-<5 years
and ≥ 5 years-it was found that the prevalence of K1,
MAD20 and RO33 allelic types in < 5 years age group and
in ≥ 5 years age group was not significantly different (p >
0.05, two-proportions test). The prevalence of multiple
clonal infections with K1 and MAD20 allelic types in < 5
years age group was significantly higher than in ≥ 5 years
age group (p = 0.017, two-proportions test); while the prevalence of multiple clonal infections with MAD20 and
RO33 allelic types was significantly higher in the ≥ 5 years
age group than in the < 5 years age group (p = 0.043, twoproportions test). However, the prevalence of total K1,
total MAD20 and total RO33 in the two age groups was
not significantly different (p > 0.05, two-proportions test).
MOI was not different among age groups, but the highest
MOI (1.8) was found in 40-95 years age group. The prevalence of K1, MAD20, RO33 and multiple clonal infections,

Table 4 Distribution of K1, MAD20 and RO33 allelic types among age groups
Age group (years)
< 5 No. (%)

5-19 No. (%)

20-39 No. (%)

40-59 No. (%)

≥ 60 No. (%)

K1

16 (7.69)

29 (13.94)

13 (6.25)

5 (2.40)

1 (0.48)

64 (30.77)

MAD20

9 (4.33)

12 (5.77)

4 (1.92)

2 (0.96)

0

27 (12.98)

5 (2.40)
22 (10.58)

6 (2.88)
15 (7.21)

1 (0.48)
4 (1.92)

0
4 (1.92)

0
0

12 (5.77)
45 (21.63)

K1 + RO33

8 (3.85)

12 (5.77)

4 (1.92)

1 (0.48)

0

25 (12.02)

MAD20 + RO33

2 (0.96)

6 (2.88)

5 (2.40)

2 (0.96)

0

15 (7.21)

K1 + MAD20 + RO33

7 (3.37)

7 (3.37)

3 (1.44)

3 (1.44)

0

39 (18.75)

40 (19.23)

16 (7.69)

10 (4.81)

1 (0.48)

msp-1 block 2 allelic type

RO33
K1 + MAD20

Multiclonal isolates
MOI

1.7

1.5

1.6

1.8

1.0

Total

69 (33.17)

87 (41.83)

34 (16.35)

17 (8.17)

1 (0.48)

Total No. (%)

20 (9.62)
106 (50.96)
1.6
208 (100.00)

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 6 of 14

Table 5 Distribution of msp-1 block 2 allelic types among parasitaemic groups from 3 regions of Lao PDR
msp-1 block 2 allelic type

Parasitaemia (cells/μl)
Number of cases (%)

Total

≤ 80

120-480

520-960

≥ 1000

K1

6 (2.88)

18 (8.65)

30 (14.42)

10 (4.80)

64 (30.76)

MAD20

1 (0.48)

7 (3.36)

14 (6.73)

5 (2.40)

27 (12.98)

RO33

2 (0.96)

4 (1.92)

6 (2.88)

0

12 (5.76)

K1 + MAD20

3 (1.44)

12 (5.76)

19 (9.13)

11 (5.28)

45 (21.63)

K1 + RO33

3 (1.44)

6 (2.88)

12 (5.76)

4 (1.92)

25 (12.01)

0

5 (2.40)

5 (2.40)

5 (2.40)

15 (7.21)

K1 + MAD20 + RO33

2 (0.96)

9 (4.32)

8 (3.84)

1 (0.48)

Multiclonal isolates

8 (3.84)

32 (15.38)

44 (21.15)

21 (10.09)

MAD20 + RO33

MOI

1.6

1.7

1.6

1.6

Total

17 (8.17)

61 (29.32)

94 (45.19)

36 (17.30)

and the overall total of each allelic type in male and
female, was not significantly different (p > 0.05, twoproportions test).
The distribution of K1, MAD20 and RO33 by estimated
parasitaemia is shown in Table 5. This study found that
the distribution of K1, MAD20, RO33 and multiple clonal
infections was not significantly different between < 480
parasites/μl and ≥ 480 parasites/μl (p > 0.05, two-proportion test). Multiplicity of P. falciparum infection was not
correlated with the estimated parasitaemia.
The nested PCR product of each K1, MAD20 and RO33
allelic type was screened for polymorphism by SSCP. The
results showed that the total polymorphic alleles (mutations) of K1, MAD20 and RO33 found in P. falciparum
isolates from Lao PDR were: 19/154 (12.34%) of total K1
alleles found in P. falciparum field isolates, 12/107
(11.21%) of total MAD20 alleles, and 6/72 (8.33%) of total
RO33 alleles, as shown in Table 6. In Oudomxay, the polymorphic alleles of K1 comprised 16.67% (1/6) of total K1
alleles, and 11.11% (1/9) of total MAD20; but no polymorphic alleles of RO33 were found. In Savannakhet, the
polymorphic alleles of K1, MAD20 and RO33 found in
P. falciparum were 11.93% (13/109) of total K1 alleles,

20 (9.61)
105 (50.48)
1.6
208 (100.00)

11.56% (8/69) of total MAD20, and 7.84% (4/51) of total
RO33. Finally, the polymorphic alleles of K1, MAD20, and
RO33 found in P. falciparum isolates from Xekong were
12.82% (5/39) of total K1 alleles, 10.34% (3/29) of total
MAD20, and 13.33% (2/15) of total RO33.
A total of 11 different allelic types of K1 were recognized by sequence alignment with P. falciparum 3D7
(XM 001352134) as shown in Figure 2. “Laos, K1 type 1”
is common found in 3 regions under study, this normal
sequence is 100% identity to P. falciparum 3D7 (XM
001352134). The remainders were regional specific,
named as “Oudomxay, K1 type 2"; “Savannakhet, K1 type
3-8” and “Xekong K1 type 9-11”.
A total of eight different alleles of MAD20 were recognized by sequence alignment with P. falciparum T836 isolate (AB276013). This MAD20 sequences from Lao PDR
aligned together with other MAD20 sequences from other
regions worldwide, is shown in Figure 3. “Laos, MAD20
type 1” is common normal sequence 100% identity to
P. falciparum T836 isolate (AB276013). The remainders
were regional specific, named as “Oudomxay, MAD20
type 2”, “Savannakhet, MAD20 type 3-6” and “Xekong,
MAD20 type 7-8”.

Table 6 The polymorphic alleles of K1, MAD20, and RO33 results by SSCP screening of P. falciparum field isolates from
Oudomxay, Savannakhet, and Xekong
msp-1 block 2 allelic
type

Oudomxay

Savannakhet

Xekong

Total

%
(polymorphic alleles/
total)

%
(polymorphic alleles/
total)

%
(polymorphic alleles/
total)

K1

16.67
(1/6)

11.93
(13/109)

12.82
(5/39)

12.34
(19/154)

MAD20

11.11
(1/9)

11.59
(8/69)

10.34
(3/29)

11.21
(12/107)

RO33

0
(0/6)

7.84
(4/51)

13.33
(2/15)

8.33
(6/72)

Total polymorphic alleles

13.33
(2/15)

10.92
(25/229)

12.05
(10/83)

11.11
(37/333)

% (polymorphic alleles/
total)

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 7 of 14

P . f a lc i p ar u m 3 D 7
L ao s , K 1 ty p e 1 (n = 1 35 ) *
O ud o m xa y , K 1 t y p e 2
(n = 1 )
S av a n na k h et , K 1 ty p e 3 (n = 3 )
S av a n na k h et , K 1 ty p e 4 (n = 1 )
S av a n na k h et , K 1 ty p e 5 (n = 2 )
S av a n na k h et , K 1 ty p e 6 (n = 1 )
S av a n na k h et , K 1 ty p e 7 (n = 4 )
S av a n na k h et , K 1 ty p e 8 (n = 2 )
X ek o n g, K 1 t yp e 9
(n = 2 )
X ek o n g, K 1 t yp e 10
(n = 2 )
X ek o n g, K 1 t yp e 11
(n = 1 )
T ha i l an d , i s ol a t e T 9 46
T ha i l an d , i s ol a t e T 9 /1 0 2
V ie t n am , is o la t e M S P 1B l 44
C am b o di a , i s ol a t e C a m8 4 I- 1
M ya n m ar , ty p e 1 4
M ya n m ar , ty p e 1 6
I nd o n es i a , i so l a te 3 /M 1
I nd i a , i s ol a te S u2 6
I nd i a , i s ol a te K e7
M al a w i, i so l at e 1/ 0 1 4- 2
P er u , i s o la t e K 1 -1 9 5 .1 8
P er u , i s o la t e K 1 -1 7 0 .9

10
20
30
40
50
60
. .. . |. . . .| . . .. | .. . . |. . . .| . . .. | .. . . |. . . .| . .. . | .. . . |. . .. | . .. . |
C TC A AA G T GG T G CA A GT G C TC A A AG T G GT G CA A G TG C T CA A AG T G GT G C AA G TG C T CA A A
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. T .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - -- - -- - - -- - - -- - -- - - C. C A .. . .. G . AC . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - -- - -- - - -- - - -- - -- - - -- - - -- - -- . . .. . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - -- - -- - - -- - - -- - -- - - -- - - -- - -- - - -- - - -- - -- - - -- - - -- - -- - - -- - - -- - - C. C A. . . .. G . AC . .. . . .. A . .. . .. G . AC . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - -- - -- - - -- - - -- - -- - - C. C A .. . .. G . AC . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - C. C A. . . .. G . AC . .. . . .. A . .. . .. G . AC . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - -- - -- - - -- - - -- - -- - - C. C A .. . .. G . AC . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - -- - -- - - -- - - -- - -- - - -- - - -- - -- . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
- -- - -- - - -C . C A. . .. . G .A C . .. . . .. A .. . . .. G . AC . .. . . .. A . .. . .. G . AC . .
- -- - -- - - -- - - -- - -- - - -- - - -- - - -- - -- - - -- . . .. . .. . . .. . . .. . .. . . .. . .

P . f a lc i p ar u m 3 D 7
L ao s , K 1 ty p e 1 (n = 1 35 ) *
O ud o m xa y , K 1 t y p e 2
(n = 1 )
S av a n na k h et , K 1 ty p e 3 (n = 3 )
S av a n na k h et , K 1 ty p e 4 (n = 1 )
S av a n na k h et , K 1 ty p e 5 (n = 2 )
S av a n na k h et , K 1 ty p e 6 (n = 1 )
S av a n na k h et , K 1 ty p e 7 (n = 4 )
S av a n na k h et , K 1 ty p e 8 (n = 2 )
(n = 2 )
X ek o n g, K 1 t yp e 9
X ek o n g, K 1 t yp e 10
(n = 2 )
X ek o n g, K 1 t yp e 11
(n = 1 )
T ha i l an d , i s ol a t e T 9 46
T ha i l an d , i s ol a t e T 9 /1 0 2
V ie t n am , is o la t e M S P 1B l 44
C am b o di a , i s ol a t e C a m8 4 I- 1
M ya n m ar , ty p e 1 4
M ya n m ar , ty p e 1 6
I nd o n es i a , i so l a te 3 /M 1
I nd i a , i s ol a te S u2 6
I nd i a , i s ol a te K e7
M al a w i, i so l at e 1/ 0 1 4- 2
P er u , i s o la t e K 1 -1 9 5 .1 8
P er u , i s o la t e K 1 -1 7 0 .9

70
80
90
10 0
1 10
120
. .. . |. . . .| . . .. | .. . . |. . . .| . . .. | .. . . |. . . .| . .. . | .. . . |. . .. | . .. . |
G TG G TG C A AG T G CT C AA A G TG G T GC A A GT G CT C A AA G T GG T AC A A GT G G TC C AA G T GG T C
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . AA . . .. . .. . . .. . A .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . G T. . .. . . .. . A .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . G TG . TA . . .G . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . C .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .G G A G. . A CA . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . G .T A .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . TA . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . GC . . .. . G T. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . GC . . A. . . .. . .. . . .. . A .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
- -- - -- - - -- - - .. . .. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. . C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .- . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .A . . .. . . G. A C. . . .. . . A. . . .. . G. A C .. . . .. . .. . . .. . . .. . .. . . .. . .
. .. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . .

P . f a lc i p ar u m 3 D 7
L ao s , K 1 ty p e 1 (n = 1 35 ) *
O ud o m xa y , K 1 t y p e 2
(n = 1 )
S av a n na k h et , K 1 ty p e 3 (n = 3 )
S av a n na k h et , K 1 ty p e 4 (n = 1 )
S av a n na k h et , K 1 ty p e 5 (n = 2 )
S av a n na k h et , K 1 ty p e 6 (n = 1 )
S av a n na k h et , K 1 ty p e 7 (n = 4 )
S av a n na k h et , K 1 ty p e 8 (n = 2 )
X ek o n g, K 1 t yp e 9
(n = 2 )
X ek o n g, K 1 t yp e 10
(n = 2 )
X ek o n g, K 1 t yp e 11
(n = 1 )
T ha i l an d , i s ol a t e T 9 46
T ha i l an d , i s ol a t e T 9 /1 0 2
V ie t n am , is o la t e M S P 1B l 44
C am b o di a , i s ol a t e C a m8 4 I- 1
M ya n m ar , ty p e 1 4
M ya n m ar , ty p e 1 6
I nd o n es i a , i so l a te 3 /M 1
I nd i a , i s ol a te S u2 6
I nd i a , i s ol a te K e7
M al a w i, i so l at e 1/ 0 1 4- 2
P er u , i s o la t e K 1 -1 9 5 .1 8
P er u , i s o la t e K 1 -1 7 0 .9

13 0
1 40
150
. .. . |. . . .| . . .. | .. . . |. . . .| . . .. | .. .
C AA - GT G G TA C A AG T CC A T CA T C TC G T TC A AA . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. A
. .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. A .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .. - .. . . .. . . .. . .. . . .. . . .. . . .. . .. -

* 10 sequences of Laos, K1 type 1 derived from sequence analysis (2 from Oudomxay, 5 from Savannakhet
and 3 from Xekong), 125 sequences were expected from SSCP screening.
Figure 2 DNA sequences of msp-1 block 2 K1 allelic types from Lao PDR aligned with K1 allelic type of P. falciparum 3D7.

Sequence analysis for RO33 allelic types from Lao
PDR revealed that there were 7 different alleles recognized by alignment with P. falciparum Sud-60-93-11
isolate (AB300615). “Lao, RO33 type 1” is common normal sequence 100% identity to P. falciparum Sud-60-93-

11 isolate (AB300615). The remainders were also regional specific, named as “Savannakhet, RO33 type 2-5”
and “Xekong, RO33 type 6-7”. This RO33 sequences
aligned together with RO33 from other regions is shown
in Figure 4.

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 8 of 14

Thai , T836 isolate
Laos , MAD20 type 1
(n =95)*
Oudo mxay, M AD20 ty pe 2
(n=1)
Sava nnakhet , MAD20 type 3 (n=1)
Sava nnakhet , MAD20 type 4 (n=4)
Sava nnakhet , MAD20 type 5 (n=2)
Sava nnakhet , MAD20 type 6 (n=1)
Xeko ng, MAD 20 type 7
(n=2)
Xeko ng, MAD 20 type 8
(n=1)
Thai , T9/94 isolat e
Camb odia, i solate Cam84I- 3
Myan mar, ty pe 6
Myan mar, ty pe 1
Viet nam, is olate M SP157
Viet nam, is olate M SP1V49
Viet nam, is olate M SP1V43
Tanz ania, i solate HN6.27
Mala wi, iso late 2/ 040-1-6
Braz il, iso late MS P1R92
Gamb ia, iso late FC R3

10
20
30
40
50
60
....|. ...|... .|....| ....|.. ..|.... |....|. ...|... .|....| ....|
AACTAG TACACCT GGTTCAG GTGGTTC AGTTACT TCAGGTG GTTCAGT TACTTCA GGTGG
...... ....... ....... ....... ....... ....... ....... ....... .....
...... ....... ....... ....... ....GG. ....... ....... ....... .....
...... ....... ....... ..AC... ....... ....... .AA.... ....... .....
...... ....... ....... .....G. ....... ....... ....... ....... .....
...... ....... ....... ..AC... ..G.GG. ....... ....... ....... .....
...... ....... ....... T.AC... ....... ....... ....... ....... .....
...... ...TT.. ....... ....... ..CAG.. ....... ....... ....... .....
...... ....... ....... ....... ....... ....... ....... ....... .....
...... ....... ......A AG..... ....G.. ....... ......G .GGC... .T..C
...... ....... ....... ....... ....... ....... .....-- ------- ----...C.. ....... ......A AG..... ..G.GGC ....T.. C...... ....... .....
...... ....... ....... ....... ....... ....... ....... ....... .....
...... ....... ......A AG..... ....... ....... ......G .GG.... .T..C
...... ....... ......A AG..... ....G.. ....... ......G .GGC... .T..C
...... ....... ....... ....... ....... ....... ......G ....... .....
------ ------- -----.A C.A..A. .CC.GG. ....... ....... ....... .....
...... ....... ....... ....... ....... ....... ......G .GG.... .T..C
...... ....... ....... ....... ....... ....... ......G .GG.... .....
...... ....... ......A AG..... ....G.. ....... ......G .GGC... .T..C

Thai , T836 isolate
Laos , MAD20 type 1
(n =95)*
Oudo mxay, M AD20 ty pe 2
(n=1)
Sava nnakhet , MAD20 type 3 (n=1)
Sava nnakhet , MAD20 type 4 (n=4)
Sava nnakhet , MAD20 type 5 (n=2)
Sava nnakhet , MAD20 type 6 (n=1)
Xeko ng, MAD 20 type 7
(n=2)
Xeko ng, MAD 20 type 8
(n=1)
Thai , T9/94 isolat e
Camb odia, i solate Cam84I- 3
Myan mar, ty pe 6
Myan mar, ty pe 1
Viet nam, is olate M SP157
Viet nam, is olate M SP1V49
Viet nam, is olate M SP1V43
Tanz ania, i solate HN6.27
Mala wi, iso late 2/ 040-1-6
Braz il, iso late MS P1R92
Gamb ia, iso late FC R3

70
80
90
100
110
120
....|. ...|... .|....| ....|.. ..|.... |....|. ...|... .|....| ....|
TTCAGT TACTTCA GTTGCT- ------- -TCAGTT GCTTCAG TTGCTTC AGTTGCT TCAGT
...... ....... ......- ------- -...... ....... ....... ....... .....
...... ....... ......- ------- -....GA ....... ....... ....... .....
...... ....... ......- ------- -...... ....... ....... ....... .....
...... ....... ......- ------- -...... ....... ....... ....... .....
...... ....... ......- ------- -...... ....... ....... ....... .....
...... ....... ....G.- ------- -...... .GC.... ....... ....... .....
...... ....... ......- ------- -...... ....... ....... ....... .....
...... ....... ......- ------- -..GTA. ....... ....... ....... .....
.....G .GGC... ......- ------- -....G. .GC.... ....... ..G..GC .....
------ ------- ------- ------- ------- ------- ------- ------- ----.....G .GG.... ......- ------- -...... ....... G..G... ..G..GC .....
...... ....... ......- ------- -...... ....... ....... ....... ....G
.....G .GG.... .G..--- ------G C...... ....... G..G... ..G..GC .....
.....- ------- -.....- ------- -....G. .GC.... ....... ..G..G. ...-.....G .GG.... ......- ------- -...... ....... ....... ..G..G. ...-.....G .GG.... ......- ------- -...... ....... ....... ..G..G. ...-.....G .GG.... ------- ------- ------- ------- ------- ------- ----.....G .GG.... .G....T CAGGTGG C...... ....... GC.G... ..G..GC .....
.....G .GGC... ......- ------- -....G. .GC.... ....... ..G..G. ...--

Thai , T836 isolate
Laos , MAD20 type 1
(n =95)*
Oudo mxay, M AD20 ty pe 2
(n=1)
Sava nnakhet , MAD20 type 3 (n=1)
Sava nnakhet , MAD20 type 4 (n=4)
Sava nnakhet , MAD20 type 5 (n=2)
Sava nnakhet , MAD20 type 6 (n=1)
Xeko ng, MAD 20 type 7
(n=2)
Xeko ng, MAD 20 type 8
(n=1)
Thai , T9/94 isolat e
Camb odia, i solate Cam84I- 3
Myan mar, ty pe 6
Myan mar, ty pe 1
Viet nam, is olate M SP157
Viet nam, is olate M SP1V49
Viet nam, is olate M SP1V43
Tanz ania, i solate HN6.27
Mala wi, iso late 2/ 040-1-6
Braz il, iso late MS P1R92
Gamb ia, iso late FC R3

130
14 0
150
....|. ...|... .|....| ....|.. ..|....
TGCTTC AGGTGGT TCA---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------...... ....... ...---- ------- ------------ ------- ------- ------- ------...... ....... ...---- ------- ------..G... .------ ------- ------- ------...... ......C ...GTTG CTTCAGG TGGTTCA
------ ------- ------- ------- ------------ ------- ------- ------- ------------ ------- ------- ------- ------------ ------- ------- ------- ------...... ......C ...GTTG CTTCAGG TGGTTCA
------ ------- ------- ------- -------

* 10 sequences of Laos, MAD20 type 1 derived from sequence analysis (2 from Oudomxay, 5 from
Savannakhet and 3 from Xekong), 85 sequences were expected from SSCP screening.
Figure 3 DNA sequences of msp-1 block 2 MAD20 allelic types from Lao PDR aligned with MAD20 allelic type of P. falciparum Thai,
T836 isolate.

Finally, each phylogenetic tree of K1, MAD20 and RO33
sequences from Lao PDR, constructed together with K1,
MAD20 and RO33 sequences from other regions worldwide, showed that some K1 allelic type sequences from
Lao PDR were grouped together with K1 allelic type

sequences from other regions. The K1 allelic type
sequence from Lao PDR known as Savannakhet isolate
type 6 was unique, and could not be grouped together
with other K1 allelic type sequences from Lao PDR or
other regions (Figure 5). The phylogenetic tree of MAD20

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 9 of 14

S ud a n , S u d- 6 0- 9 3 -1 1 is o la t e
L ao s , R O 3 3 t yp e 1 ( n =6 6 )*
S av a n na k h et , R O 3 3 t y pe 2( n = 1)
S av a n na k h et , R O 3 3 t y pe 3( n = 1)
S av a n na k h et , R O 3 3 t y pe 4( n = 1)
S av a n na k h et , R O 3 3 t y pe 5( n = 1)
X ek o n g, R O3 3 t y p e 6
( n = 1)
X ek o n g, R O3 3 t y p e 7
( n = 1)
T ha i l an d , c l on e 81 4 C
T ha i l an d , i s ol a t e T 8 38
C am b o di a , C a m8 4 I -5 i so l at e
I nd o n es i a , i so l a te 4 /M 1
I nd i a , R D TC F 00 2
I ra n , i s o la t e C H 10
M al a w i, 2 /0 4 0- 1 - 8 i s ol a te
M al a w i, 2 /0 4 1- 3 - 1 i s ol a te
S ud a n , S u d- 6 0- 9 3 -3
T an z a ni a , i s ol a t e I F A1 7 .2 9
W es t Af r i ca PF A M SA 1 is o la t e
G ha n a , i s ol a te R O3 3
B ra z i l, 7 G8 is o l at e
P er u , R O 3 3- 1 40 . 1 i s o la t e

10
20
30
40
50
60
.. . .| . . .. | . .. . |. . . .| . . .. | . .. . |. . . .| . . .. | .. . . |. . . .| . .. . | .. . . |
CA A AG C C TG C A GA T GC T G TA A G TA C T CA A AG T G CT A A AA A TC C T CC A G GT G CT A C AG T A C
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .T G T .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . T. G .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . AG . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .A G . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . C AA . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .G . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .G . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .G . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .G . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .G . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .. . .. . . .. . . .

S ud a n , S u d- 6 0- 9 3 -1 1 is o la t e
L ao s , R O 3 3 t yp e 1 ( n =6 6 )*
S av a n na k h et , R O 3 3 t y pe 2( n = 1)
S av a n na k h et , R O 3 3 t y pe 3( n = 1)
S av a n na k h et , R O 3 3 t y pe 4( n = 1)
S av a n na k h et , R O 3 3 t y pe 5( n = 1)
X ek o n g, R O3 3 t y p e 6
( n = 1)
X ek o n g, R O3 3 t y p e 7
( n = 1)
T ha i l an d , c l on e 81 4 C
T ha i l an d , i s ol a t e T 8 38
C am b o di a , C a m8 4 I -5 i so l at e
I nd o n es i a , i so l a te 4 /M 1
I nd i a , R D TC F 00 2
I ra n , i s o la t e C H 10
M al a w i, 2 /0 4 0- 1 - 8 i s ol a te
M al a w i, 2 /0 4 1- 3 - 1 i s ol a te
S ud a n , S u d- 6 0- 9 3 -3
T an z a ni a , i s ol a t e I F A1 7 .2 9
W es t Af r i ca PF A M SA 1 is o la t e
G ha n a , i s ol a te R O3 3
B ra z i l, 7 G8 is o l at e
P er u , R O 3 3- 1 40 . 1 i s o la t e

70
80
90
.. . .| . . .. | . .. . |. . . .| . . .. | . .. . |. . .
CT T CA G G TA C T GC A AG T A CT A A AG G T GC T AT A A
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . T G. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .
.. . .. . . .. . . .. . .. . . .. . . .. . . .. . .. . .

* 10 sequences of Laos, RO33 type 1 derived from sequence analysis (2 from Oudomxay, 5 from
Savannakhet and 3 from Xekong), 56 sequences were expected from SSCP screening.
Figure 4 DNA sequences of msp-1 block 2 RO33 allelic types from Lao PDR aligned with RO33 allelic type of P. falciparum Thai,
Sudan, Sud-60-93-11 isolate.

allelic type sequences from Lao PDR and from other
regions showed that they were grouped together with the
monophyletic clade in only 34% of bootstrap replications
(Figure 6). Most of RO33 allelic type sequences from Lao
PDR, however (except Laos, RO33 type 1), were not
grouped together with RO33 allelic type sequences from
other regions worldwide (Figure 7).

Discussion
Human malaria is an infectious disease transmitted by the
bite of mosquitoes infected with any of five Plasmodium
species: P. falciparum, P. vivax, P. malariae, P. ovale and
Plasmodium knowlesi. Among these species, P. falciparum
can cause various clinical problems including heart, lung,
kidney and brain damage, and possibly death. P. falciparum remains an important public health concern
because of its increasing resistance to common anti-malarial drugs, resulting in a high mortality rate. In malaria-

endemic areas, infections by multiple parasite clones are
frequent, and clone fluctuation may be a logical strategy
for the appearance of strain-specific responses [25-28].
This study investigated the prevalence and polymorphism of P. falciparum subpopulations in three regions of
Lao PDR by nested PCR. This nested PCR method cannot
be used to distinguish alleles nearly identical or identical
in size, but differing in sequences [29]. Polymorphic banding by size of all parasite isolates in this study was not
observed by agarose gel electrophoresis of the nested PCR
products because all isolates were the same or very nearly
the same size. To distinguish polymorphism in allele-specific families in this study, all DNA products from each
allele-specific family detected by nested PCR were
screened by SSCP. The different band patterns from SSCP
were selected, and these nested PCR products were
sequenced. This study found that sequences that had only
one nucleotide base change could produce a different

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 10 of 14

P. falciparum 3D7
Others
Malawi, isolate 1/014-2

73 Indonesia, isolate 3/M1
Xekong, K1 type 10

31

Laos, K1 type 1

Lao PDR
Lao PDR

Peru, isolate K1-170.9

14

Asia

Others

Savannakhet, K1 type 8

Lao PDR

Savannakhet, K1 type 7

10

Lao PDR

Oudomxay, K1 type 2

6

Lao PDR
Xekong, K1 type 11

39
27

Savannakhet, K1 type 3
Lao PDR
Xekong, K1 type 9

37

Savannakhet, K1 type 4
Savannakhet, K1 type 5

56

Lao PDR
Lao PDR

Vietnam, isolate MSP1Bl44
India, isolate Ke7

49

Asia

Asia

Myanmar, type 14
Myanmar, type 16

84

Asia

Thailand, isolate T9/102
Thailand, isolate T946

58

Asia
India, isolate Su26
Cambodia, isolate Cam84I-1
Peru, isolate K1-195.18
Savannakhet, K1 type 6

0.07

0.06

0.05

0.04

0.03

0.02

0.01

Asia

Others
Lao PDR

0.00

Figure 5 Phylogenetic tree of described P. falciparum field isolates from Lao PDR and other regions worldwide based on their K1
allelic type. The evolutionary history was inferred using the UPGMA method. The optimal tree with the sum of branch length = 0.40987732 is
shown. The percentage of replicate trees in which the taxa clustered together in the bootstrap test (1,000 replicates) is shown.

banding pattern on SSCP, as seen in Xekong isolate K1
type 10 and Savannakhet isolate MAD20 type 4. Moreover, nested PCR could not detect P. falciparum isolates,
which have polymorphic allele sequences because of insertion or deletion of a few nucleotide bases. The prevalence
of polymorphic strains found in each msp-1 block 2 allelic
type in this study may be underestimated because of variations in sensitivity which occurred throughout the experiment due to weak bands, as well as in the estimation of
band length, as suggested by Aubouy et al. [22].

Nevertheless, the P. falciparum isolate K1 allelic type
was found to be the most prevalent in Lao PDR, as is the
case in other regions worldwide: K1, MAD20 and RO33
allelic types comprised 66.95%, 46.52% and 31.30%, respectively, of samples in the present study. When observing
the three allelic types in the three regions of Lao PDR
separately, this study found that the MAD20 allelic type
was more prevalent than the others in Oudomxay, the
least malaria-endemic area of Lao PDR. However, the
number of samples collected from Oudomxay was low

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 11 of 14

Thai, T836 isolate
Asia
Cambodia, isolate Cam84I-3
Laos, MAD20 type 1

Lao PDR

46 Xekong, MAD20 type 8
Myanmar, type 1

Lao PDR

Asia

Brazil, isolate MSP1R92

46

Others

Vietnam, isolate MSP1V43

28

Asia

Malawi, isolate 2/040-1-6

Others

Savannakhet, MAD20 type 4

21

Oudomxay, MAD20 type 2

19

Xekong, MAD20 type 7

Lao PDR
Lao PDR

Vietnam, isolate MSP157
Gambia, isolate FCR3

33

87

Lao PDR

Asia
Others

Thai, T9/94 isolate

67

Asia
Vietnam, isolate MSP1V49
Savannakhet, MAD20 type 5
Savannakhet, MAD20 type 3

23

Savannakhet, MAD20 type 6

34

Tanzania, isolate HN6.27
Myanmar, type 6

0.20

0.15

0.10

Lao PDR

0.05

Others

Asia

0.00

Figure 6 Phylogenetic tree of described P. falciparum field isolates from Lao PDR and other regions worldwide based on their MAD20
allelic type sequences. The evolutionary history was inferred using the UPGMA method. The optimal tree with the sum of branch length was
1.13478897. The percentage of replicate trees in which the taxa clustered together in the bootstrap test (1,000 replicates) is shown.

due to the sampling formula, which depended on the prevalence of malaria infection in this region. The distribution
of K1, MAD20 and RO33 allelic types in highly endemic
areas such as Savannakhet and Xekong provinces had the
same patterns and the same overall distribution as the
total three regions.
Monomorphic banding of K1 and MA20 allelic types in
Lao PDR observed on agarose gel electrophoresis may be
due to limited samples group with clinical symptoms in
this study, or due to the fact that clonal fluctuations in
each msp-1 block 2 allelic types of P. falciparum isolate in
Lao PDR is quite low. Moreover, it may be due to low
parasite density in the blood samples under study (majority of parasite density < 1,000 cells/μl). Limited clonal fluctuation of K1 allelic type was also seen in urban malaria
infected patients (200 and 220 bp) in Burkina Faso [30]
and in Darjeeling district, West Bengal state of India (140

bp) [11]. Moreover, monomorphic band of MAD20 (220
bp) and RO33 (150/160 bp) were also found in some districts in eastern and northeastern India [11].
However, the total P. falciparum msp-1 block 2 genotypic isolates, multiple clonal infections and MOI in this
study might be underestimated, because the new MR
allele type, as described by Takala et al. [17], was not
investigated. Takala et al. reported that the MR allele
type in P. falciparum isolates in Asembo Bay, Kenya, was
found in 29% of the samples. Happi et al. [18] found a
proportion of K1 (79%), MAD20 (32%) and RO33 (38%)
alleles in P. falciparum isolates from Nigeria. The frequency of MAD20 in the study by Happi et al. was lower
than in this study and in studies from other regions.
Aubouy et al. [22] studied the polymorphism in two
MSP-1 and MSP-2 genes from Gabon. They found that
MSP-1 alleles of K1, MAD20 and RO33 comprised

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

Page 12 of 14

M alawi, 2/041-3-1 is o late
Gh an a, is o late RO33
Tan zan ia, is o late IFA 17.29
Oth ers
Su d an , Su d -60-93-3

33

Su d an , Su d -60-93-11 is o late
Peru , RO33-140.1 is o late
Th ailan d , clo n e 814C
Lao s , RO33 ty p e 1

A s ia
Lao PDR

W es t A frica PFA M SA 1 is o late

39

In d ia, RDTCF002

A s ia

M alawi, 2/040-1-8 is o late

Oth ers

Camb o d ia, Cam84I-5 is o late

17

In d o n es ia, is o late 4/M 1
Brazil, 7G8 is o late

64
7

Oth ers

A s ia
A s ia

Oth ers

Th ailan d , is o late T838

A s ia

Iran , is o late CH10

13

Sav an n akh et, RO33 ty p e 3
Sav an n akh et, RO33 ty p e 4

Lao PDR

Sav an n akh et, RO33 ty p e 5

22

Lao PDR

Lao PDR

Xeko n g , RO33 ty p e 7

Lao PDR

Xeko n g , RO33 ty p e 6

Lao PDR

Sav an n akh et, RO33 ty p e 2

0.020

0.015

0.010

0.005

Lao PDR

0.000

Figure 7 Phylogenetic tree of described P. falciparum field isolates from Lao PDR and other regions worldwide based on RO33 allelic
type. The evolutionary history was inferred using the UPGMA method. The optimal tree with the sum of branch length was 0.12513671. The
percentage of replicate trees in which the taxa clustered together in the bootstrap test (1,000 replicates) is shown.

90.4%, 63.5% and 36.5% of the samples studied; they also
found that P. falciparum polymorphism was extensive in
southeast Gabon, and that most infections were composed of multiple clones. About 45.65% (105/230) of P.
falciparum infections in Lao PDR in this study were multiple clonal infections of the three allele types studied.
Kang et al. [10] studied genetic polymorphism of msp-1
and msp-2 in P. falciparum field isolates from Myanmar,
and found that the K1 allele infection rate was 73.02%
(46/63); but the majority (63.5%) occurred as multiple
clonal infections with the MAD20 allele type. This study
found that total multiple clonal infections of K1 and
MAD20 (including K1 + MD20 + RO33) was lower than
that found in Myanmar (28.26% vs. 63.5%), but that single infection with K1 was higher (27.8% vs. 9.5%). Otherwise, single infection with MAD20 in Lao PDR was lower
than in Myanmar (11.7% vs. 27%).
MOI has been suggested to differ in relation to age,
transmission intensity and parasite density [31-33]. MOI
in Lao PDR was rather low as not exceed 2.0, and was

not correlated with age group like the previous report by
Vafa et al. [33]. The overall MOI in Lao PDR (1.6) was
not different from the MOI reported in Vietnam (1.76)
and Brazil (1.42), but lower than in Tanzania (2.37) and
in Gabon (4.0) [22,34]. There were many reports showed
that the MOI was correlated with parasite density. MOI
in this study did not increase with higher parasite density,
similar to those reports in Brazzaville, Republic of Congo
and in Gabon [22,35]. This study used clinical P. falciparum isolates from patients with clinical symptoms, so
that the MOI may be lower than that reported in asymptomatic children [36]. Many reported showed that MOI
would reflect that infected individual has immunity
against malaria [32,37]. Thus, the MOI should be studied
in asymptomatic P. falciparum-infected population in
Lao PDR further, especial in children.
The frequency of polymorphic alleles in the K1 allele
type in Lao PDR and in Myanmar was not markedly different (12.34% vs. 9.5%), but the frequency of

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

polymorphism in the MAD20 allelic type from Myanmar
was much higher than that from Lao PDR (27% vs.
11.21%).
Lao PDR is a landlocked country with a long-space
area. Ethnic minority populations are very localized distribution. Migration of the population within the country and cross-country is relatively low. Thus, the spread
of polymorphic clones of msp-1 block2 allelic types of P.
falciparum is limited to residents. Polymorphism of the
K1, MAD20 and RO33 allelic types may occur in confined areas. Based on sequence data analysis and phylogenetic tree of each K1, MAD20 and RO33 allelic type
sequences in Lao PDR with allelic type sequence data
reported in other areas worldwide, found that Savannakhet, K1 type 6 and Savannakhet, RO33 type 2 may be
unique polymorphic allelic types of P. falciparum-clinical isolate in Lao PDR.

Conclusion
Genetic polymorphism with diverse allelic types was
identified in msp-1 block 2 in P. falciparum clinical isolates from Lao PDR. A rather high level of multiple clonal infections was also observed, but the degree of
multiplicity of infection was rather low as not exceed
2.0. Clonal fluctuation in each allelic type was not
observed. Most of the polymorphic sequences of each
K1, MAD20 and RO33 allelic type were regional specific. This basic genetic data of msp-1 block 2 allelic types
is useful for treatment and malaria control program in
Lao PDR.
Acknowledgements
We are grateful to the patients who participated in the study, as well as
their parents and guardians. We thank Human Research Development to
Neighboring Countries for NK’s scholarship, and the Graduate School, Khon
Kaen University, for a generous research grant. Finally we thank Mr.
Christopher Salisbury for suggestions and assistance with the Englishlanguage presentation of the manuscript.
Author details
Faculty of Medical Technology, University of Health Science, Vientiane, Lao
PDR. 2Department of Pathology, Faculty of Medicine, Khon Kaen University,
123 Mittraphap Highway, Khon Kaen 40002, Thailand. 3Department of
Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen
University, 123 Mittraphap Highway, Khon Kaen 40002, Thailand.
4
Department of Epidemiology, Faculty of Public Health, Khon Kaen
University, 123 Mittraphap Highway, Khon Kaen 40002, Thailand.
5
Department of Clinical Microscopy, Faculty of Associated Medical Sciences,
Khon Kaen University, 123 Mittraphap Highway, Khon Kaen 40002, Thailand.
1

Authors’ contributions
The work presented here was carried out in collaboration between all
authors. NK, PK and OK were the principal investigators responsible for the
study design, data collection and analysis, and manuscript preparation. PK
and JD provided valuable technical guidance, and LC provided valuable
statistical guidance. All authors read and approved the final version of the
manuscript.
Competing interests
The authors declare that they have no competing interests.

Page 13 of 14

Received: 16 August 2011 Accepted: 17 December 2011
Published: 17 December 2011
References
1. Vythilingam I, Sidavong B, Chan ST, Phonemixay T, Vanisaveth V, Sisoulad P,
Phetsouvanh R, Hakim SL, Phompida S: Epidemiology of malaria in
Attapeu Province, Lao PDR in relation to entomological parameters.
Trans R Soc Trop Med Hyg 2005, 99:833-839.
2. Jorgensen P, Nambanya S, Gopinath D, Hongvanthong B,
Luangphengsouk K, Bell D, Phompida S, Phetsouvanh R: High
heterogeneity in Plasmodium falciparum risk illustrates the need for
detailed mapping to guide resource allocation: a new malaria risk map
of the Lao People’s Democratic Republic. Malar J 2010, 9:59.
3. Khaminsou N, Kritpetcharat O, Daduang J, Kritpetcharat P: A survey of
malarial infection in endemic areas of Savannakhet province, Lao PDR
and comparative diagnostic efficiencies of Giemsa staining, acridine
orange staining, and semi-nested multiplex PCR. Parasitol Int 2008,
57:143-149.
4. Phetsouvanh R, Vythilingam I, Sivadong B, Hakim SL, Chan ST, Phompida S:
Endemic malaria in four villages in Attapeu Province, Lao PDR. Southeast
Asian J Trop Med Public Health 2004, 35:547-551.
5. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, Saul A, Rare L,
Baisor M, Lorry K, Brown GV, Pye D, Irving DO, Smith TA, Beck HP,
Alpers MP: A recombinant blood-stage malaria vaccine reduces
Plasmodium falciparum density and exerts selective pressure on parasite
populations in a phase 1-2b trial in Papua New Guinea. J Infect Dis 2002,
185:820-827.
6. Healer J, Murphy V, Hodder AN, Masciantonio R, Gemmill AW, Anders RF,
Cowman AF, Batchelor A: Allelic polymorphisms in apical membrane
antigen-1 are responsible for evasion of antibody-mediated inhibition in
Plasmodium falciparum. Mol Microbiol 2004, 52:159-168.
7. Takala SL, Escalante AA, Branch OH, Kariuki S, Biswas S, Chaiyaroj SC, Lal AA:
Genetic diversity in the Block 2 region of the merozoite surface protein
1 (MSP-1) of Plasmodium falciparum: additional complexity and selection
and convergence in fragment size polymorphism. Infect Genet Evol 2006,
6:417-424.
8. Genton B, Al-Yaman F, Betuela I, Anders RF, Saul A, Baea K, Mellombo M,
Taraika J, Brown GV, Pye D, Irving DO, Felger I, Beck HP, Smith TA,
Alpers MP: Safety and immunogenicity of a three-component bloodstage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium
falciparum in Papua New Guinean children. Vaccine 2003, 22:30-41.
9. Reed ZH, Kieny MP, Engers H, Friede M, Chang S, Longacre S, Malhotra P,
Pan W, Long C: Comparison of immunogenicity of five MSP1-based
malaria vaccine candidate antigens in rabbits. Vaccine 2009, 27:1651-1660.
10. Kang JM, Moon SU, Kim JY, Cho SH, Lin K, Sohn WM, Kim TS, Na BK:
Genetic polymorphism of merozoite surface protein-1 and merozoite
surface protein-2 in Plasmodium falciparum field isolates from Myanmar.
Malar J 2010, 9:131.
11. Joshi H, Valecha N, Verma A, Kaul A, Mallick PK, Shalini S, Prajapati SK,
Sharma SK, Dev V, Biswas S, Nanda N, Malhotra MS, Subbarao SK, Dash AP:
Genetic structure of Plasmodium falciparum field isolates in eastern and
north-eastern India. Malar J 2007, 6:60.
12. Holder AA, Blackman MJ: What is the function of MSP-I on the malaria
merozoite? Parasitol Today 1994, 10:182-184.
13. Conway DJ, Cavanagh DR, Tanabe K, Roper C, Mikes ZS, Sakihama N,
Bojang KA, Oduola AMJ, Kremsner PJ, Arnot DE, Greenwood BM,
McBride JS: A principal target of human immunity to malaria identified
by molecular population genetic and immunological analyses. Nat Med
2000, 6:689-692.
14. Ferreira MU, Ribeiro WL, Tonon AP, Kawamoto F, Rich SM: Sequence
diversity and evolution of the malaria vaccine candidate merozoite
surface protein-1 (MSP-1) of Plasmodium falciparum. Gene 2003,
304:65-75.
15. Woehlbier U, Epp C, Kauth CW, Lutz R, Long CA, Coulibaly B, Kouyaté B,
Arevalo-Herrera M, Herrera S, Bujard H: Analysis of antibodies directed
against merozoite surface protein 1 of the human malaria parasite
Plasmodium falciparum. Infect Immun 2006, 74:1313-1322.
16. Holder AA, Guevara Patiño JA, Uthaipibull C, Syed SE, Ling IT, ScottFinnigan T, Blackman MJ: Merozoite surface protein 1, immune evasion,
and vaccines against asexual blood stage malaria. Parassitologia 1999,
41:409-414.

Khaminsou et al. Malaria Journal 2011, 10:371
http://www.malariajournal.com/content/10/1/371

17. Takala S, Branch O, Escalante AA, Kariuki S, Wootton J, Lal AA: Evidence for
intragenic recombination in Plasmodium falciparum: identification of a
novel allele family in block 2 of merozoite surface protein-1: Asembo
Bay Area Cohort Project XIV. Mol Biochem Parasitol 2002, 125:163-171.
18. Happi CT, Gbotosho GO, Sowunmi A, Falade CO, Akinboye DO, Gerena L,
Kyle DE, Milhous W, Wirth DF, Oduola AMJ: Molecular analysis of
Plasmodium falciparum recrudescent malaria infections in children
treated with chloroquine in Nigeria. Am J Trop Med Hyg 2004, 70:20-26.
19. Bereczky S, Mårtensson A, Gil JP, Färnert A: Short report: Rapid DNA
extraction from archive blood spots on filter paper for genotyping of
Plasmodium falciparum. Am J Trop Med Hyg 2005, 72:249-251.
20. World Health Organization: Basic Malaria Microscopy. Part 1. Learner’s Guide.
Geneva 2010.
21. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN: Identification of
the four human malaria parasite species in field samples by the
polymerase chain reaction and detection of a high prevalence of mixed
infections. Mol Biochem Parasitol 1993, 58:283-292.
22. Aubouy A, Migot-Nabias F, Deloron P: Polymorphism in two merozoite
surface proteins of Plasmodium falciparum isolates from Gabon. Malar J
2003, 2:12.
23. Huby-Chilton F, Beveridge I, Gasser RB, Chilton NB: Single-strand
conformation polymorphism analysis of genetic variation in
Labiostrongylus longispicularis from kangaroos. Electrophoresis 2001,
22:1925-1929.
24. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5:
Molecular Evolutionary Genetics Analysis using maximum likelihood,
evolutionary distance, and maximum parsimony methods. Mol Biol Evol
2011.
25. Contamin H, Fandeur T, Rogier C, Bonnefoy S, Konate L, Trape JF,
Mercereau-Puijalon O: Different genetic characteristics of Plasmodium
falciparum isolates collected during successive clinical malaria episodes
in Senegalese children. Am J Trop Med Hyg 1996, 54:632-643.
26. Robert F, Ntoumi F, Angel G, Candito D, Rogier C, Fandeur T, Sarthou JL,
Mercereau-Puijalon O: Extensive genetic diversity of Plasmodium
falciparum isolates collected from patients with severe malaria in Dakar,
Senegal. Trans R Soc Trop Med Hyg 1996, 90:704-711.
27. Färnert A, Rooth I, Svensson A, Snounou G, Björkman A: Complexity of
Plasmodium falciparum infections is consistent over time and protects
against clinical disease in Tanzanian children. J Infect Dis 1999,
179:989-995.
28. Zwetyenga J, Rogier C, Tall A, Fontenille D, Snounou G, Trape JF,
Mercereau-Puijalon O: No influence of age on infection complexity and
allelic distribution in Plasmodium falciparum infections in Ndiop, a
Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med
Hyg 1998, 59:726-735.
29. Miller LH, Roberts T, Shahabuddin M, McCutchan TF: Analysis of sequence
diversity in the Plasmodium falciparum merozoite surface protein-1
(MSP-1). Mol Biochem Parasitol 1993, 59:1-14.
30. Soulama I, Nebie I, Ouedraogo A, Gansane A, Diarra A, Tiono AB,
Bougouma EC, Konate AT, Kabre GB, Taylor WR, et al: Plasmodium
falciparum genotypes diversity in symptomatic malaria of children living
in an urban and a rural setting in Burkina Faso. Malar J 2009, 8:135.
31. Smith T, Felger I, Tanner M, Beck HP: Premunition in Plasmodium
falciparum infection: Insights from the epidemiology of multiple
infections. Trans R Soc Trop Med Hyg 1999, 93(Suppl 1):59-64.
32. Konate L, Zwetyenga J, Rogier C, Bischoff E, Fontenille D, Tall A, Spiegel A,
Trape JF, Mercereau-Puijalon O: Variation of Plasmodium falciparum msp1
block 2 and msp2 allele prevalence and of infection complexity in two
neighbouring Senegalese villages with different transmission conditions.
Trans R Soc Trop Med Hyg 1999, 93(Suppl 1):21-28.
33. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F:
Multiplicity of Plasmodium falciparum infection in asymptomatic children
in Senegal: relation to transmission, age and erythrocyte variants. Malar
J 2008, 7:17.
34. Ferreira MU, Kaneko O, Kimura M, Liu Q, Kawamoto F, Tanabe K: Allelic
diversity at the merozoite surface protein-1 (MSP-1) locus in natural
Plasmodium falciparum populations: a brief overview. Mem Inst Oswaldo
Cruz 1998, 93:631-8.
35. Mayengue PI, Ndounga M, Malonga FV, Bitemo M, Ntoumi F: Genetic
polymorphism of merozoite surface protein-1 and merozoite surface

Page 14 of 14

protein-2 in Plasmodium falciparum isolates from Brazzaville, Republic of
Congo. Malar J 2011, 10:276.
36. Magesa SM, Mdira KY, Babiker HA, Alifrangis M, Farnert A, Simonsen PE,
Bygbjerg IC, Walliker D, Jakobsen PH: Diversity of Plasmodium falciparum
clones infecting children living in a holoendemic area in north-eastern
Tanzania. Acta Trop 2002, 84:83-92.
37. Franks S, Koram KA, Wagner GE, Tetteh K, McGuinness D, Wheeler JG,
Nkrumah F, Ranford-Cartwright L, Riley EM: Frequent and persistent,
asymptomatic Plasmodium falciparum infections in African infants,
characterized by multilocus genotyping. J Infect Dis 2001, 183:796-804.
doi:10.1186/1475-2875-10-371
Cite this article as: Khaminsou et al.: Genetic analysis of the merozoite
surface protein-1 block 2 allelic types in Plasmodium falciparum clinical
isolates from Lao PDR. Malaria Journal 2011 10:371.

Submit your next manuscript to BioMed Central
and take full advantage of:
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at
www.biomedcentral.com/submit

</pre>
</body>
</html>
